Omega-3 (EPA+DHA)
DHA-forward fish or algal oil
Strong
Several good studies agree
Strong: 51 RCTs with ~3,000 participants, a clear dose–response for blood pressure across 71 RCTs, and mechanistic coherence (membrane effects on sinus-node cells). Effect sizes are modest but highly consistent.
Across 51 studies it lowered resting heart rate by about 2 beats per minute and improved heart rate variability, a sign of better recovery. Over 8 to 12 weeks that is a change your device can show you.
The largest meta-analysis on the topic — 51 trials — found omega-3 lowers resting heart rate by about 2 beats per minute, an effect driven by DHA rather than EPA. Fish-oil trials also increase vagally-mediated heart-rate variability. This is one of the few supplement effects large and steady enough to see in a wearable's resting-heart-rate trend over two to three months.
DHA incorporates into cardiac cell membranes, slowing pacemaker cells and shifting autonomic balance toward the parasympathetic side.
Anyone with a low omega-3 index; DHA-forward oils for heart-rate effects; 4–12 weeks to see it. Keep to ≤3 g/day — higher prescription doses carry an atrial-fibrillation signal.
We compare each effect with how much that number normally swings from one night to the next. An effect smaller than the swing is real, but you will not see it in a week of data.
- Resting heart rateProbably visibleeffect: 2.23 bpmnormal swing: ±2 bpm
- Resting heart rate (DHA-only trials)Probably visibleeffect: 2.47 bpmnormal swing: ±2 bpm
What to buy
- ✓EPA+DHA per serving ≥1,000 mg (not 'fish oil 1,000 mg')
- ✓DHA-forward ratio for heart-rate effects
- ✓Triglyceride form, IFOS 5-star tested
- ✕Doses ≥4 g/day (atrial-fibrillation signal)
- ✕Rancid-smelling products
- · Mild bleeding-time increase — caution with anticoagulants; stop 2 weeks pre-surgery.
- · Atrial fibrillation signal at ≥4 g/day — stay ≤3 g.
As an Amazon Associate, Umbral earns from qualifying purchases. Product data is provided by Amazon and may change; ratings and prices shown are Amazon’s, not Umbral’s. Recommendations are based on the evidence grade and the form used in trials, never on commission.

DHA is what drives the resting-heart-rate effect.
Buy on Amazon
Algae is where fish get their DHA in the first place, so this skips the fish entirely — no fishy burps, no mercury question, and it works for vegans.
Buy on Amazon
Liquid gets you a gram-plus of omega-3 in one teaspoon instead of four softgels, and the lemon masks it. The highest-rated omega-3 here at 4.8 stars.
Buy on AmazonPrefer to compare yourself? This opens Amazon’s full selection for this supplement, filtered to the form we recommend.
See all on AmazonEvery result, next to the line that means no effect
Each diamond is a study's best estimate. The thin line shows how sure the study was: the shorter the line, the more certain the result.
- Resting heart ratebpm · Hidayat 2018−2.23−3.07 … −1.40
- Resting heart rate (DHA-only trials)bpm · Hidayat 2018−2.47[not given]
- Systolic blood pressure (2–3 g/day)mmHg · Zhang 2022−2.00[not given]
- Systolic BP in hypertensivesmmHg · Zhang 2022−4.50[not given]
Each unit gets its own scale, so numbers are never mixed on one line. When a study gave no range, we leave it blank instead of inventing one.
3 studies over 9 years
The studies
- 1.Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trialsEuropean Journal of Clinical Nutrition · 2018 · meta-analysis · 51 experiments · n = 3,000
Heart rate −2.23 bpm (95% CI −3.07 to −1.40); DHA −2.47 bpm; EPA alone no effect.
- 2.Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trialsAmerican Journal of Clinical Nutrition · 2013 · meta-analysis · 15 experiments
Increased high-frequency (vagal) HRV with fish oil.
- 3.Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trialsJournal of the American Heart Association · 2022 · meta-analysis · 71 experiments · n = 4,973
Optimal BP reduction at 2–3 g/day EPA+DHA; larger in hypertensive participants.
Umbral is a wellness product, not a medical device. It does not diagnose, treat, cure or prevent any disease. Supplement information is educational; talk to a clinician before starting anything, especially if you are pregnant, under 18, managing a condition or taking medication.
These statements have not been evaluated by the Food and Drug Administration.